Baseline | PLR | Preinfusion | After VE | |
---|---|---|---|---|
CO, L/min | ||||
Responders | 5.40 ± 2.25 | 6.54 ± 2.53b | 5.33 ± 2.43 | 6.81 ± 2.81c |
Non-responders | 6.51 ± 2.47 | 7.03 ± 2.73b | 6.48 ± 2.52 | 6.85 ± 2.89c |
SV, mL | ||||
Responders | 53.5 ± 26.3a | 63.8 ± 26.5b | 52.5 ± 26.9a | 68.1 ± 27.5c |
Non-responders | 76.4 ± 31.3 | 82.7 ± 33.5b | 76.3 ± 30.9 | 81.5 ± 33.1c |
HR, b.p.m. | ||||
Responders | 106 ± 25a | 106 ± 24a | 106 ± 26a | 103 ± 24a |
Non-responders | 88 ± 20 | 87 ± 18 | 87 ± 20 | 86 ± 19 |
FTc, ms | ||||
Responders | 292 ± 51a | 323 ± 50b | 291 ± 52a | 327 ± 54c |
Non-responders | 343 ± 61 | 360 ± 74b | 342 ± 62 | 355 ± 83 |
Acc, m/s 2 | ||||
Responders | 9.6 ± 4.5 | 9.7 ± 4.9 | 9.3 ± 4.6 | 10.4 ± 5.4c |
Non-responders | 10.3 ± 3.9 | 10.5 ± 4.1 | 10.3 ± 3.9 | 10.7 ± 4.7 |
SAP, mmHg | ||||
Responders | 107 ± 21 | 120 ± 21b | 108 ± 21 | 122 ± 25c |
Non-responders | 107 ± 14 | 111 ± 16b | 105 ± 15 | 111 ± 18c |
DAP, mmHg | ||||
Responders | 61 ± 11 | 65 ± 12b | 61 ± 12 | 64 ± 12c |
Non-responders | 63 ± 11 | 66 ± 10b | 63 ± 10 | 65 ± 10c |
MAP, mmHg | ||||
Responders | 76 ± 14 | 83 ± 13b | 75 ± 14 | 83 ± 15c |
Non-responders | 78 ± 12 | 82 ± 12b | 77 ± 12 | 81 ± 13c |
PP, mmHg | ||||
Responders | 45.8 ± 15.7 | 55.3 ± 18.3b | 46.9 ± 13.6 | 57.7 ± 19.7a, c |
Non-responders | 42.1 ± 10.1 | 45.2 ± 11.9b | 42.1 ± 11.3 | 45.9 ± 12.9c |
CPO, W | ||||
Responders | 0.92 ± 0.44 | 1.22 ± 0.49b | 0.91 ± 0.47 | 1.25 ± 0.51c |
Non-responders | 1.10 ± 0.38 | 1.26 ± 0.46b | 1.11 ± 0.43 | 1.23 ± 0.53c |
TSVR, dyn·s·cm -5 | ||||
Responders | 1264 ± 442 | 1143 ± 368b | 1299 ± 481 | 1130 ± 451c |
Non-responders | 1124 ± 535 | 1091 ± 510 | 1119 ± 504 | 1133 ± 538 |
PETCO 2 , mmHg | ||||
Responders | 35 (30 to 37) | 38 (33 to 40)b | 35 (29 to 37) | 36 (30 to 38)c |
Non-responders | 34 (30 to 37) | 35 (30 to 38)b | 34 (29 to 37) | 34 (28 to 37) |